Endothelial function and inflammation in coronary artery disease

D Tousoulis, M Charakida… - Postgraduate medical …, 2008 - academic.oup.com
Evidence supports the central role of endothelium and inflammation in all phases of the
atherosclerotic process. Clinical studies have shown their prognostic potential for the …

Historical analysis of PAI-1 from its discovery to its potential role in cell motility and disease

C Dellas, DJ Loskutoff - Thrombosis and haemostasis, 2005 - thieme-connect.com
Although plasminogen activator inhibitor 1 (PAI-1) is one of the primary regulators of the
fibrinolytic system, it also has dramatic effects on cell adhesion, detachment and migration …

Interferon gamma: a master regulator of atherosclerosis

JE McLaren, DP Ramji - Cytokine & growth factor reviews, 2009 - Elsevier
Atherosclerosis is a chronic inflammatory disease that is characterized by the development
of fibrotic plaques in the arterial wall. The disease exhibits a complex aetiology and its …

Visfatin/NAMPT: a multifaceted molecule with diverse roles in physiology and pathophysiology

TB Dahl, S Holm, P Aukrust… - Annual review of …, 2012 - annualreviews.org
Visfatin/NAMPT (nicotinamide phosphoribosyltransferase) is a protein with several
suggested functions. Although the first discovery of this molecule as a pre-B-cell colony …

Flaxseed and cardiovascular health

K Prasad - Journal of cardiovascular pharmacology, 2009 - journals.lww.com
Flaxseed and its components may improve cardiovascular health because of their numerous
attributes. Flaxseed contains 35% of its mass as oil, of which 55% is α-linolenic acid (ALA) …

The impact of long-chain n-3 polyunsaturated fatty acids on human health

CHS Ruxton, PC Calder, SC Reed… - Nutrition research …, 2005 - cambridge.org
A considerable literature has been published on the health benefits of fish, oil-rich fish and
fish oils and their constituent long-chain (LC) n-3 PUFA. Evidence from epidemiological …

Neurotrophin presence in human coronary atherosclerosis and metabolic syndrome: a role for NGF and BDNF in cardiovascular disease?

GN Chaldakov, M Fiore, IS Stankulov, L Manni… - Progress in brain …, 2004 - Elsevier
The development of atherosclerotic cardiovascular disease is a common comorbidity in
patients with the metabolic syndrome, a concurrence of cardiovascular risk factors in one …

Protein C and thrombomodulin in human acute lung injury

LB Ware, X Fang, MA Matthay - American Journal of …, 2003 - journals.physiology.org
Decreased circulating protein C and increased circulating thrombomodulin are markers of
the prothrombotic, antifibrinolytic state associated with poor outcomes in sepsis but have not …

Cathepsin L expression and regulation in human abdominal aortic aneurysm, atherosclerosis, and vascular cells

J Liu, GK Sukhova, JT Yang, J Sun, L Ma, AN Ren… - Atherosclerosis, 2006 - Elsevier
The cysteine protease cathepsin L is one of the most potent mammalian elastases and
collagenases, widely expressed at basal levels in most tested tissues and cell types, and …

[HTML][HTML] Oxidative stress and accelerated vascular aging: implications for cigarette smoking

A Csiszar, A Podlutsky, MS Wolin… - … in bioscience: a …, 2009 - ncbi.nlm.nih.gov
Cigarette smoking is the major cause of preventable morbidity and mortality in the United
States and constitutes a major risk factor for atherosclerotic vascular disease, including …